{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-138953","form_type":"8-K","ticker":"MDGL","cik":"0001157601","company_name":"MADRIGAL PHARMACEUTICALS, INC.","filed_at":"2023-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.070759+00:00","generated_at":"2026-06-15T08:12:42.361775+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Madrigal ups ATM equity facility by $200M to raise additional capital via Cowen","bullets":["Amendment to Sales Agreement with Cowen increases ATM capacity by $200M.","Shares sold through 'at-the-market' offerings under existing shelf registration.","Company has no obligation to sell; Cowen acts as agent on commercially reasonable efforts.","Prospectus supplement filed May 9, 2023 for the additional $200M of common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-138953","json":"https://secwatch.observer/filing/0001193125-23-138953.json","markdown":"https://secwatch.observer/filing/0001193125-23-138953.md","text":"https://secwatch.observer/filing/0001193125-23-138953.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1157601/000119312523138953/0001193125-23-138953-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1157601/000119312523138953/d416547d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T08:12:42.361775+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}